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PEthnicity and LV Hypertrophy
Left Ventricular Mass and Ventricular
Remodeling Among Hispanic Subgroups
Compared With Non-Hispanic Blacks and Whites
MESA (Multi-Ethnic Study of Atherosclerosis)
Carlos J. Rodriguez, MD, MPH,*‡ Ana V. Diez-Roux, MD, PHD,§ Andrew Moran, MD, MPH,*
Zhezhen Jin, PHD,† Richard A. Kronmal, PHD, Joao Lima, MD,¶ Shunichi Homma, MD,*
David A. Bluemke, MD, PHD,# R. Graham Barr, MD, DRPH*‡
New York, New York; Ann Arbor, Michigan; Seattle, Washington; and Baltimore and Bethesda, Maryland
Objectives The purpose of this study was to examine the prevalence of left ventricular hypertrophy (LVH) and left ventricular (LV)
remodeling patterns within Hispanic subgroups compared with non-Hispanic whites in the MESA (Multi-Ethnic Study of
Atherosclerosis).
Background Hispanics are the largest and fastest-growing ethnic minority in the U.S., but there are no data on LVH and LV
geometry among Hispanic subgroups.
Methods Cardiac magnetic resonance imaging was performed in 4,309 men and women age 45 to 84 years without clini-
cal cardiovascular disease. Hispanics were categorized into subgroups based on self-reported ancestry. LVH was
defined as the upper 95th percentile of indexed LV mass in a reference normotensive, nondiabetic, nonobese
population, and LV remodeling according to the presence/absence of LVH and abnormal/normal LV mass to LV
end-diastolic volume ratio.
Results Among Hispanic participants, 574 were of Mexican origin, 329 were of Caribbean origin, and 161 were of Cen-
tral/South American origin. On unadjusted analysis, only Caribbean-origin Hispanics (prevalence ratio  1.2;
95% confidence interval [CI]: 1.03 to 1.4) had greater prevalence of hypertension than non-Hispanic whites.
Hispanic subgroups were more likely to have LVH than non-Hispanic whites after adjustment for hypertension
and other covariates (Caribbean-origin Hispanics  odds ratio [OR]: 1.8, 95% CI: 1.1 to 3.0; Mexican-origin Hispanics
 OR: 2.2, 95% CI: 1.4 to 3.3; Central/South Americans  OR: 1.5, 95% CI: 0.7 to 3.1). All Hispanic subgroups also
had a higher prevalence of concentric and eccentric hypertrophy compared with non-Hispanic whites (p  0.001).
Conclusions Caribbean-origin Hispanics had a higher prevalence of LVH and abnormal LV remodeling compared with non-
Hispanic whites. A higher prevalence of LVH and abnormal LV remodeling was also observed among Mexican-
origin Hispanics, despite a lower prevalence of hypertension. Differences among Hispanic subgroups regarding
LVH and LV remodeling should be taken into account when evaluating cardiovascular risk in this
population. (J Am Coll Cardiol 2010;55:234–42) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.046I
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Hispanics are the largest minority ethnic group in the U.S.,
umbering 46 million people or 16% of the U.S. population
1,2). Sixty-seven percent of Hispanics in the U.S. are of
exican origin, 19% come from the Caribbean (principally
rom Puerto Rico, Cuba, and the Dominican Republic), and
4% originate from Central and South America (3,4).
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nstitutes of Health, Bethesda, Maryland. This research was supported by contracts andirect evidence suggests that the prevalence of hyperten-
ion differs among these Hispanic subgroups: the prevalence
f hypertension was lower among Mexican-origin Hispanics
han among non-Hispanic whites and non-Hispanic blacks
n one cohort (5), whereas the prevalence of hypertension
mong Caribbean-origin Hispanics was higher and similar to
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January 19, 2010:234–42 LV Mass and Remodeling Across Hispanic Subgroupshat of non-Hispanic whites and blacks, respectively, in an-
ther (6,7).
Left ventricular hypertrophy (LVH), as defined by in-
reased left ventricular mass (LVM), is a marker of subclin-
cal cardiovascular disease (CVD) and a powerful, indepen-
ent predictor of CVD morbidity and mortality among
ispanics and non-Hispanics (8,9). Abnormal left ventric-
lar (LV) remodeling may also carry an incremental risk
ndependent of LVH (10). Three abnormal LV remodeling
atterns have been identified: concentric hypertrophy, ec-
entric hypertrophy, and concentric remodeling (11,12).
ach pattern of LVM distribution appears to carry a
ifferent risk for cardiovascular (CV) events (13).
In addition to the prevalence of hypertension, Hispanic
ubgroups also differ with respect to ancestry/race (14),
ocioeconomic factors (15), and dietary and lifestyle risk
actors for CVD (2,16), which could influence increased
VM and LV remodeling differentially among Hispanic
ubgroups. The prevalence of LVM and LV remodeling
cross Hispanic subgroups remains unknown. We therefore
xamined the prevalence of LVH and LV remodeling
atterns on cardiac magnetic resonance imaging (MRI) in
ispanic subgroups compared with non-Hispanic whites in
he MESA (Multi-Ethnic Study of Atherosclerosis). We
pecifically hypothesized that Mexican-origin Hispanics
ould have a similar prevalence of increased LVM and
bnormal LV remodeling compared with non-Hispanic
hites; Caribbean-origin Hispanics would have a higher
revalence; and Central/South Americans would have in-
ermediate values.
ethods
he characteristics of subjects enrolled in MESA have been
escribed elsewhere (17). Between July 2000 and September
002, 6,814 men and women age 45 to 84 years were
nrolled from 6 U.S. communities (Baltimore; New York;
os Angeles; Forsyth County, North Carolina; Chicago;
nd St. Paul, Minnesota). Participants were recruited from
ethnic groups: non-Hispanic white, non-Hispanic black,
ispanic, and Chinese. Non-Hispanic white participants
ere recruited at all sites, non-Hispanic black participants
ere recruited at all sites except St. Paul, and Hispanic
articipants were recruited in New York, Los Angeles, and
t. Paul. All participants were free of clinical CVD at
nrollment. Institutional review boards at all study centers
pproved the study protocol. Informed consent was ob-
ained from every participant.
aseline examination. Demographic characteristics, in-
luding age, sex, educational attainment, medical history,
edication, alcohol, and tobacco use, were ascertained by
uestionnaire. Race and ethnicity were based on responses
o questions modeled on the 2000 U.S. census. All partic-
pants who self-identified as Hispanics where categorized as
ispanic and were asked to further self-identify as Cuban,
ominican, Mexican, Puerto Rican, or other Hispanic. clucose and total and high-
ensity lipoprotein cholesterol
evels were measured after a 12-h
ast. Presence of diabetes melli-
us was based on self-reported
hysician diagnosis, use of insu-
in and/or oral hypoglycemic
gent, or a fasting glucose value
126 mg/dl. Physical activity was
elf-reported as number of min-
tes per week spent in moderate or
igorous activities, which allowed
or determination of metabolic
quivalents/min/week of physical
ctivity. Family annual income and
ducation were each classified into
groups: $20,000, $20,000 to
49,999, and$50,000 andhigh
chool, completed high school with
r without some college, and com-
leted college or more, respectively.
lood pressure and hypertension assessment. Resting
lood pressure was measured using the Dinamap Monitor
RO 100 (Critikon, Tampa, Florida) automated oscillo-
etric device. Three measurements were obtained at 1-min
ntervals with the subject in the seated position with back
nd arm supported after 5 min of rest with an appropriate-
ized cuff, with the cuff at the level of the heart, using a
tandardized protocol. The average of the second and third
easurements was recorded as the resting blood pressure.
ypertension was defined as a systolic blood pressure 140
m Hg, a diastolic blood pressure 90 mm Hg, or
urrently taking medications for blood pressure control (18).
ardiac MRI protocol. The reliability of the MRI read-
ngs has been previously reported (19). Myocardial volume
as determined from the difference between epicardial and
ndocardial LV volumes calculated by modified Simpson’s
ule. A series of LV end-diastolic short-axis images was
reated starting at the mitral annulus and advancing through
he ventricle to apex at 10-mm intervals. Papillary muscles
ere excluded from LVM analysis. LVM was calculated
rom the product of myocardial volume and specific gravity
1.05 g/ml) as previously described (20).
Preliminary evaluation showed that MRI-measured
VM and volume indexed by body-surface area, height2.7,
r height1.9 did not fully remove the correlation of these
easures with weight and/or height. Using an allometric
pproach (21,22), regression models for body size were
erived from a reference sample of MESA participants
ithout hypertension, diabetes mellitus, or obesity as pre-
iously described (22), so that the equation would reflect the
ormal physiology free from disease or obesity that might
istort the relationship of height and weight and LVM. The
ndex derived multiplied by 100 is equivalent to the per-
Abbreviations
and Acronyms
BMI  body mass index
CI  confidence interval
CV  cardiovascular
CVD  cardiovascular
disease
LV  left ventricular
LVH  left ventricular
hypertrophy
LVM  left ventricular
mass
M-C  mass-cavity ratio
MRI  magnetic resonance
imaging
OR  odds ratio
PR  prevalence ratioentage of the value predicted on the basis of height, weight,
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LV Mass and Remodeling Across Hispanic Subgroups January 19, 2010:234–42nd sex in a normal population. LVM was adjusted for body
ize by dividing 100  LVM by the predicted LVM based
n height, weight, and sex, as: 100 LVM/(a height0.54
eight0.61), where a  6.82 for women and 8.25 for men
ith mass in grams, height in meters, and weight in
ilograms. Similarly, the body size-adjusted LV end-
iastolic volume was computed as: 100 LV volume/(b
eight1.25  weight0.43), where b  10.0 for women and
0.5 for men, and LV end-diastolic volume is in milliliters.
ody surface area was used to index LVM in a confirmatory
nalysis. Presence of LVH was defined by a percent-
redicted LVM value greater than the 95th upper percentile
stimated (from empirical cumulative distribution) sepa-
ately for men and women.
LV remodeling analysis was determined by unadjusted
VM/LV end-diastolic volume ratio (mass to cavity [M-C]
atio). Geometric classification of LV architecture by echo-
ardiography relies on measurement of relative wall thick-
ess. The M-C ratio is conceptually the MRI equivalent of
elative wall thickness. An abnormal M-C ratio was defined
s an M-C ratio greater than the sex-specific 95th percentile
f control subjects without the conditions described above.
V remodeling was classified into patterns of eccentricity:
Figure 1 Diagram of LV Remodeling Patterns Based on LVH an
Four types of left ventricular (LV) remodeling patterns are described based on pres
volume (M-C) ratio: normal, with LVH absent and normal M-C ratio; concentric rem
present and normal M-C ratio; and concentric hypertrophy, with LVH present and in
Rob Flewell.ormal (normal LVM, normal M-C ratio), concentric
emodeling (normal LVM, high M-C ratio), eccentric
ypertrophy (high LVM, normal M-C ratio), and concen-
ric hypertrophy (high LVM, high M-C ratio) as previously
escribed (12) (Fig. 1).
tatistical analysis. Hispanic subgroups were categorized
ased on self-report as Mexican- or Caribbean- (Domini-
an, Puerto Rican, or Cuban) origin Hispanic. Of the
emainder identifying as “other Hispanic,” 93% were born
n Central or South America and were hence categorized as
f Central/South American origin. Both non-Hispanic
hites and non-Hispanic blacks were used as reference
roups because Hispanics are often a mixture of these 2
acial groups; Asians were excluded from analyses. Distri-
utions of risk factors, mean LVM, prevalence of LVH, and
entricular remodeling categories were compared using
hi-square for categorical variables and analysis of variance
or continuous variables.
Because prevalence of hypertension was close to 50%,
nadjusted and adjusted prevalence ratios (PRs) and 95%
onfidence intervals (CIs) were calculated by relative risk
egression using SAS PROC GENMOD procedure with
og-link and binomial error. Logistic regression analysis was
M-C Ratio
absence of left ventricular hypertrophy (LVH) and the LV mass/LV end-diastolic
, with LVH absent and increased M-C ratio; eccentric hypertrophy, with LVH
ed M-C ratio. Partition value for elevated M-C ratio was 2.0. Figure illustration byd LV
ence/
odeling
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January 19, 2010:234–42 LV Mass and Remodeling Across Hispanic Subgroupssed to assess the odds ratio (OR) and 95% CI of LVH and
levated M-C ratio among non-Hispanic whites, non-
ispanic blacks, and each Hispanic subgroup. Multivariate
inear regression models were based on LVM percent
redicted as a continuous variable. To assess the relative
ontribution of different sets of covariates (potential con-
ounders) on the LVH and M-C ratio differences observed,
e compared estimates across a series of sequential adjust-
ent models: model 1 (adjusted for age and sex); in model
, socioeconomic factors (insurance, education, income)
ere added to model 1; model 3 added metabolic factors
diabetic status, body mass index [BMI], total and high-
ensity lipoprotein cholesterol) to model 2; model 4 added
ehavioral factors (physical activity, cigarette smoking) to
odel 3; and model 5 added systolic blood pressure,
iastolic blood pressure, and use of antihypertensive medi-
ations to model 4. The relative proportion of risk explained
y each set of factors was estimated as follows: (ORprior model –
Rsubsequent model)/ORprior model  1)  100.
Statistical significance was defined as 2-tailed p value0.05; no
djustment was made for multiple comparisons given the
escriptive nature of this study, but all major comparisons are
eported (23).
esults
f 6,814 MESA participants, 1,810 lacked MRI measures,
53 were Asian, and 42 did not provide information on
ispanic subgroup. Of the remaining 4,309 included par-
icipants, 1,064 were Hispanic: 574 (54%) of Mexican, 329
aseline Characteristics by Race-Ethnicity and Hispanic SubgroupTable 1 Baseline Characteristics by Race-Ethnicity and Hispan
Non-Hispanic
White
(n  1,959)
Non-H
B
(n 
Age, yrs 62.1 10.1 61.6
Sex, male/female 47.3/52.7 45.5
Education
High school 4.1 1
High school with or without some college 42.9 5
Bachelor’s degree 53.0 3
Income
20,000 10.1 2
$20,000 to $49,999 31.8 4
$50,000 58.1 3
Insurance status, % private 81.5 7
Diabetes 7.3 1
Impaired fasting glucose 23.4 2
Metabolic syndrome 29.3 3
Body mass index, kg/m2 27.3 4.7 29.4
Current smoker 12.8 1
High-density lipoprotein cholesterol, mg/dl 52.5 15.8 53.1
Exercise, metabolic equivalent/h/week 28. 37.4 31.3
Current alcohol use 72.0 5
Systolic blood pressure, mm Hg 122.4 20.3 130.7
Diastolic blood pressure, mm Hg 70.0 10.1 74.7alues are expressed as mean  SD or %.31%) of Caribbean, and 161 (15%) of Central/South
merican origin. Compared with participants without
RI, included participants were slightly younger, had lower
verage systolic blood pressure and BMI, and were less
ikely to have hypertension or diabetes, as previously de-
cribed (24). These differences were nondifferential across
ispanic subgroups.
emographics and cardiac risk factors among Hispanic
ubgroups. Age and sex distributions were similar across
on-Hispanic whites, African-Americans, and Hispanic
ubgroups; however, educational attainment, income, and
he proportion with private insurance were lower for all
ispanic subgroups compared with both whites and
frican-Americans in this sample (Table 1). Mexican-
rigin Hispanics had a higher mean BMI than other
ispanic subgroups, similar to non-Hispanic blacks, and
he greatest prevalence of diabetes and metabolic syndrome.
ypertension among Hispanic subgroups. The preva-
ence of hypertension across Hispanic subgroups is shown in
able 2 in comparison with whites and non-Hispanic
lacks. Non-Hispanic blacks had the highest prevalence of
ypertension overall (unadjusted PR: 1.6; 95%: CI: 1.5 to
.7 vs. whites), and Caribbean-origin Hispanics had the
ighest prevalence of hypertension among Hispanic sub-
roups (unadjusted PR: 1.2; 95% CI: 1.03 to 1.4). There
ere no significant differences in hypertension prevalence
etween Central/South Americans (unadjusted PR: 1.1;
5% CI: 0.9 to 1.4) or Mexican-origin Hispanics (unad-
usted PR: 1.0; 95% CI: 0.9 to 1.1) and non-Hispanic
bgroup
ic
)
Mexican-Origin
Hispanic
(n  574)
Caribbean-Origin
Hispanic
(n  329)
South or Central
American
(n  161)
60.7 10.1 59.4 10.2 60.5 10.1
52.3/47.7 49.2/50.8 42.2/57.8
43.7 42.3 37.3
48.6 45.6 47.2
7.7 12.2 15.5
35.6 38.5 43.0
46.2 43.1 41.8
18.2 18.5 15.2
55.8 63.8 50.9
22.8 13.7 13.0
29.8 30.5 32.3
46.9 31.4 35.4
29.5 4.7 28.3 4.2 28.2 4.4
14.1 18.5 13.0
.6 46.5 12.9 48.4 13.0 50.1 13.5
.9 22.7 35.3 24.7 31.6 19.231.7
49.5 49.9 48.1
.4 126.4 22.7 125.4 20.4 125.019.8
.2 70.8 10.4 73.5 9.1 71.59.8ic Su
ispan
lack
1,286
 9.9
/54.5
0.3
4.4
5.3
0.2
0.7
9.1
5.1
9.1
5.7
2.1
 5.2
9.4
 15
 50
1.0
 21
 10
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LV Mass and Remodeling Across Hispanic Subgroups January 19, 2010:234–42hites. After adjustment for age, sex, education, income,
hysical activity, BMI, current alcohol use, smoking, and
iabetes, the prevalence of hypertension remained higher
mong non-Hispanic blacks (adjusted PR: 1.05; 95% CI:
.02 to 1.08) and, of borderline statistical significance,
mong Caribbean-origin Hispanics (adjusted PR: 1.05; 95%
I: 1.0 to 1.10) compared with non-Hispanic whites.
VH among Hispanic subgroups. Despite the modest or
bsent differences in hypertension prevalence between His-
anics and non-Hispanic whites, all Hispanic subgroups
ad higher LVH prevalence than non-Hispanic whites
Table 2, Fig. 2). This result was not sensitive to indexing
ethodology (percent predicted or body surface area).
here were weak but significant linear relationships be-
ween systolic blood pressure and LVM; Pearson r  0.13
o 0.22 among the racial/ethnic subgroups; all p  0.01.
iastolic blood pressure was not correlated with LVM.
In age- and sex-adjusted models, Caribbean-origin His-
anics and Mexican-origin Hispanics had twice the odds of
aving LVH as non-Hispanic whites. Sequential adjust-
ent for combined socioeconomic indexes resulted in a 23%
eduction in effect size versus only 10% among Caribbean-
ypertension and Left Ventricular Hypertrophy by Race-Ethnicity anTable 2 Hypertension and Left Ventricular Hypertrophy by Race
Non-Hispanic
White
(n  1,959)
Non-His
Blac
(n  1,
% with treated hypertension* 32.2 49.
% with hypertension† 36.4 56.
LVM (g) 143.7 38.3 157.7
Indexed LVM (% predicted) 101 17 107
Indexed LVM (body surface area, g/m2) 75.8 15.2 81.3
M-C ratio 1.14 0.24 1.24
rude prevalence rates are reported. Values expressed as mean SD or %. *Treated hypertension
Hypertension was defined as blood pressure 140 mm Hg systolic or 90 mm Hg diastolic, or
M-C  mass-cavity; LVM  left ventricular mass.
Figure 2 Prevalence of LVH and Elevated M-C Ratio by Race-Et
Different indexing methodologies for left ventricular hypertrophy (LVH) are presente
body-surface area (BSA). M-C ratio  LVM/LV end-diastolic volume; partition valuerigin Hispanics and 12% among non-Hispanic blacks.
ddition of metabolic covariates including BMI had min-
mal effects on the ORs for LVH among all Hispanics
ubgroups or non-Hispanic blacks. Additional adjustment
or blood pressure reduced the odds of LVH for Caribbean-
rigin Hispanics and non-Hispanic blacks by 36% and 20%,
espectively (Table 3). After adjustment for all covariates, all
ispanic subgroups had a higher percent-predicted LVM
ompared with non-Hispanic whites, specifically 5.0 U
arger for Mexican-origin Hispanics, 5.0 U larger for
aribbean-origin Hispanics, and 3.0 U larger for Central/
outh Americans (Fig. 3). A separate analysis substituting
VM indexed by body surface area in all our regression
odels yielded qualitatively similar results.
V geometry among Hispanic subgroups. Compared
ith those with normal LV geometry, those with concentric
ypertrophy were 53% more likely to be hypertensive, with
ystolic and diastolic blood pressures 23.8 and 8.3 mm Hg
igher, respectively. All Hispanic subgroups had a higher
revalence of concentric hypertrophy compared with non-
ispanic whites, with Mexican-origin Hispanics having the
ighest prevalence, similar to that of non-Hispanic blacks.
panic Subgroupsicity and Hispanic Subgroups
Mexican-Origin
Hispanic
(n  574)
Caribbean-Origin
Hispanic
(n  329)
South or Central
American
(n  161)
27.5 38.0 28.0
36.8 42.6 40.4
148.9 38.5 146.0 37.1 137.7 37.0
106 19 107 18 105 20
81.0 16.8 80.4 15.6 77.7 16.5
1.18 0.24 1.16 0.25 1.15 0.23
ned as a history of a physician diagnosis of hypertension and taking antihypertensive medication.
ated hypertension.
ty and Hispanic Subgroup
luding percent-predicted (MESA [Multi-Ethnic Study of Atherosclerosis]) and
vated M-C ratio was 2.0. NH  non-Hispanic; other abbreviations as in Figure 1.d His-Ethn
panic
k
286)
1
9
41.6
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January 19, 2010:234–42 LV Mass and Remodeling Across Hispanic Subgroupsccentric hypertrophy was most common among non-
ispanic blacks and all Hispanic subgroups compared with
on-Hispanic whites. Among Hispanic subgroups, preva-
ence of concentric remodeling was not increased compared
ith non-Hispanic whites (Fig. 4). In contrast, only non-
ispanic blacks had a significantly increased risk for ele-
ated M-C ratio compared with non-Hispanic whites. In
equential covariate adjustments or in the full multivariate
odel for LV remodeling, the results did not change
ignificantly, except among non-Hispanic blacks (Table 4).
separate analysis substituting LVM indexed by body
urface area in all our regression models yielded qualitatively
imilar results.
iscussion
e report an increased prevalence of LVH among Hispanic
ubgroups compared with non-Hispanic whites. Caribbean-
rigin Hispanics had a 2-fold increased odds of LVH
ompared with non-Hispanic whites, which was in part due
o an elevated prevalence of hypertension. Mexican-
dds Ratios of Left Ventricular Hypertrophy by Race-Ethnicityn Hispanic Subgroups After Sequ ntial Adjustment for CovariatesTable 3 Odds Ratios of Left Ventricular H pertrophy by R ce-Etand Hispanic Subgroups After Sequential Adjustment f
Non-Hispanic
White
(n  1,959)
Non
(n
Unadjusted 1.0 2.6
Model 1 (age and sex) 1.0 2.7
Model 2 (model 1  socioeconomic factors)* 1.0 2.5
Model 3 (model 2  metabolic variables)† 1.0 2.5
Model 4 (model 3  behaviors)‡ 1.0 2.4
Model 5 (model 4  blood pressure variables)§ 1.0 1.9
Socioeconomic factors are income, education, and insurance. †Metabolic variables include diab
igarette smoking and physical activity. §Blood pressure includes systolic and diastolic blood pres
-2
-1
0
1
2
3
4
5
6
7
8
non-Hispanic black Mexican-origin His
s
Figure 3 LVM Difference in Means From Non-Hispanic Whites
Multivariate regression modeling of left ventricular mass (LVM) percent predicted arigin Hispanics had a similar 2-fold increased odds of
VH compared with non-Hispanic whites, despite no
ncrease in the prevalence of hypertension. All Hispanic
ubgroups had a significantly higher prevalence of con-
entric and eccentric hypertrophy compared with non-
ispanic whites.
eterogeneity of the Hispanic population/Hispanic sub-
roups. These data suggest that Hispanics are not mono-
ithic with respect to CV risk, but that different subgroups
riginating in different geographic areas of Latin America
anifest significant differences in the distribution of LVH
nd the type of ventricular remodeling. This is concordant
ith other studies demonstrating that CVD risk factors and
easures of subclinical atherosclerosis differ between His-
anic subgroups (25).
In the U.S. Hispanic population, heart disease and stroke
re the leading cause of mortality (26). LVH has been
ecognized as important for CV prognosis (8); however,
ispanics remain understudied with regard to LVH and
V risk factors among their respective subgroups. Concerns
ty
variates
nic
86)
Mexican-Origin
Hispanic
(n  574)
Caribbean-Origin
Hispanic
(n  329)
South or Central
American
(n  161)
.4) 2.2 (1.5–3.1) 1.8 (1.2–2.9) 1.5 (0.8–2.8)
.5) 2.3 (1.6–3.2) 2.0 (1.3–3.1) 1.5 (0.8–2.9)
.5) 2.0 (1.4–3.0) 1.9 (1.2–3.1) 1.2 (0.6–2.5)
.3) 2.1 (1.4–3.1) 1.9 (1.2–3.1) 1.2 (0.6–2.6)
.2) 2.2 (1.5–3.3) 2.0 (1.2–3.2) 1.3 (0.7–2.7)
.6) 2.2 (1.4–3.3) 1.8 (1.1–3.0) 1.5 (0.7–3.1)
tus, body mass index, and total and high-density lipoprotein cholesterol. ‡Behaviors included are
d use of antihypertensive medications.
Caribbean-origin Hispanics South/Central Americans
ntinuous variable by race-ethnicity and Hispanic subgroups.hnici
or Co
-Hispa
Black
 1,2
(2.0–3
(2.0–3
(2.0–3
(1.8–3
(1.8–3
(1.4–2panics
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ion that Hispanics are less susceptible to CVD than the
eneral population. This perception, known as the “His-
Figure 4 Percent Breakdown of 4 LV Remodeling Patterns
Across Race-Ethnicity and Hispanic Subgroups
Prevalence of abnormal left ventricular (LV) remodeling patterns is higher
among Hispanic subgroups compared with non-Hispanic (NH) whites (differ-
ences were significant at the p  0.0001 level). Figure illustration by Rob
Flewell.
dds Ratios of Ventricular Remodeling (Elevated M-C Ratio >95thy Race-Ethnicity and Hispanic Subgroup After Sequential AdjustmTable 4 Odds Ratios of Ventricular Remod ling (Elevate M-Cby Race-Ethnicity and Hispanic Subgroup After Sequen
Non-Hispanic
White
(n  1,959)
Non
(n
Unadjusted 1.0 1.9
Model 1 (age and sex) 1.0 2.1
Model 2 (model 1  socioeconomic factors)* 1.0 1.9
Model 3 (model 2  metabolic variables)† 1.0 1.7
Model 4 (model 3  behaviors)‡ 1.0 1.7
Model 5 (model 4  blood pressure variables)§ 1.0 1.4Socioeconomic factors are income, education, and insurance. †Metabolic factors are body mass index, di
moking and physical activity. §Blood pressure variables include systolic and diastolic blood pressure ananic Paradox,” contends that Hispanics have lower CV
ortality risk than non-Hispanic whites (27), but this
ypothesis may not apply uniformly across subgroups of
ispanics. The Hispanic Paradox has been contradicted in
ecent studies (28). Our findings demonstrate that Hispan-
cs are a CV high-risk group and highlight the fact that
ispanic subgroup differences need to be appreciated when
onsidering CV risk.
V geometry among Hispanic subgroups. Because in-
reased LVM can be physiologic or pathologic, cardiac
imensions and remodeling must be considered. Concentric
ypertrophy is associated with more adverse patterns of
arget organ damage than either eccentric hypertrophy or
oncentric remodeling (29,30). Koren et al. (31) reported
hat hypertensive patients with concentric LVH had the
ighest risk of mortality, followed by those with eccentric
VH and concentric remodeling. Caribbean- and Mexican-
rigin Hispanics in particular had increased prevalence of
oncentric hypertrophy compared with non-Hispanic
hites. In contrast, elevated M-C ratio alone was not
ignificantly different among the Hispanic subgroups rela-
ive to non-Hispanic whites.
ifferential determinants of LVH among Hispanic sub-
roups. The increased prevalence of LVH and abnormal
V remodeling among Mexican-origin Hispanics, despite a
ower prevalence of hypertension, is an interesting and
nexpected finding. This may be related to elevated preva-
ence rates of obesity, diabetes, and metabolic syndrome
bserved in our cohort of Mexican-origin Hispanics. Dia-
etic patients without overt heart disease have been shown
o have cardiac structural changes similar to those caused by
VH (32,33). Furthermore, many of those with diabetes or
etabolic syndrome may not be diagnosed with hyperten-
ion, even though their systolic blood pressure is above the
oal of 130/80 mm Hg.
It is not surprising that significant differences in LVH
xisted despite modest differences in hypertension preva-
ence because LVH has several determinants besides blood
ressure or established hypertension. Furthermore, changes
n LVM can occur in the setting of changes in adrenergic
tate, such as with psychosocial stress, despite overt changes
n blood pressure (34). Adjustment for socioeconomic
entile)r Covariates>95th Percentile)
djustment for Covariates
nic
86)
Mexican-Origin
Hispanic
(n  574)
Caribbean-Origin
Hispanic
(n  329)
South or Central
American
(n  161)
.3) 1.1 (0.8–1.5) 1.1 (0.8–1.7) 0.9 (0.5–1.6)
.6) 1.2 (0.9–1.6) 1.3 (0.9–1.9) 1.0 (0.6–1.8)
.3) 0.9 (0.7–1.3) 1.0 (0.7–1.6) 0.7 (0.4–1.3)
.1) 0.8 (0.5–1.1) 1.0 (0.7–1.5) 0.6 (0.3–1.2)
.1) 0.8 (0.6–1.1) 1.0 (0.7–1.6) 0.7 (0.4–1.2)
.8) 0.8 (0.6–1.2) 0.9 (0.6–1.4) 0.7 (0.4–1.3)Percent foRa io
tial A
-Hispa
Black
 1,2
(1.6–2
(1.7–2
(1.5–2
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(1.1–1abetic status, and total and high-density lipoprotein cholesterol. ‡Behaviors included are cigarette
d use of antihypertensive medications.
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January 19, 2010:234–42 LV Mass and Remodeling Across Hispanic Subgroupsovariates accounted for a fraction of the odds of having
VH among Mexican-origin Hispanics. Socioeconomic
ndexes may be better reflectors of changes in blood pressure
ver the life course accounting for unmeasured behavioral
actors as well as levels of psychosocial stress (7).
Although disparities regarding hypertension awareness,
ontrol, and treatment rates among non-Hispanic blacks
nd whites may be making steps toward being eliminated
35), the same may not hold true for Hispanics and their
espective subgroups (5). In our cohort, Mexican-origin
ispanics had significantly lower levels of hypertension
reatment than non-Hispanic whites and other Hispanic
ubgroups. This may be related to issues of access to care,
atient–physician relationships, or medication adherence
nd would affect levels of target organ damage in this
ispanic subgroup, despite lower hypertension prevalence.
The role of acculturation in the development of hyper-
ension and LVH among Hispanics is conflicting and
oorly studied. In some studies, acculturation seemed to be
strong predictor of hypertension (36), although other
tudies of Mexican-origin Hispanics showed that the pro-
ess of acculturation was not a major predictor (37).
enetic ancestry as a potential determinant of LVH
mong Hispanic subgroups. Latin American populations
riginated as a result of the Spanish conquest of the
mericas and subsequent admixture between Native Amer-
can, European, and West African individuals. Caribbean-
rigin Hispanic and Mexican-origin Hispanic populations
re genetically and culturally very different, even if both are
onsidered to be Hispanic. Genetic admixture studies in
amples of Hispanics in the western and southwestern U.S.
eflect mostly European and Native American admixture
38). Hispanics in the eastern and northeast U.S. conform
ore closely to predominating European and West African
dmixture (39). Given a higher proportion of West African
ncestry, Caribbean-origin Hispanics may be more salt-
ensitive, thus affecting their prevalence of hypertension,
VH, and abnormal LV remodeling (40). Whether geo-
raphic ancestral origins contribute to the differential dis-
ribution of disease among Hispanic subgroups remains to
e studied.
tudy limitations. Although population-based, MESA is
ot a representative sample of the U.S. Hispanic population
ue to its design and the exclusion of those with prevalent
VD. Furthermore, the sample who completed MRI were
ealthier than the overall cohort. Hence, our sample repre-
ents a lower-risk group compared with the entire commu-
ity, which is likely to have underestimated the burden of
VH in the Hispanic population. Blood pressure measure-
ents used in this analysis were recorded at a single office
isit, which may affect the estimate of hypertension preva-
ence and the ability to adjust for lifetime experience of
ypertension. We indexed LVM using body-surface area as
ell as allometric scaling, which is the methodology best
upported by the current literature (21). Both models
ielded qualitatively similar results. We used percent-redicted LVM as our measure of heart size to remove the
ffect of the normal physiologic relation of body size and
eart size and allow for a more sensitive measure of
ifferences between the racial/ethnic groups that is indepen-
ent of their different body size characteristics. However,
VM differences in our race-ethnic groups may be due in
art to residual confounding by body size. Unmeasured
ariables may account for some of the observed differences.
or example, Hispanic subgroup classification may be a
urrogate for other psychosocial factors that may have
ontributed to these disparities. Virtually all Caribbean-
rigin Hispanics came from the East Coast sites, and a large
roportion Mexican-origin Hispanics came from the West
oast sites. Whether or not this differential distribution
aused any potential for confounding by site and thus bias in
ur analyses is unclear.
onclusions
o our knowledge, this is the first comparative analysis of
ispanic subgroups in a single cohort. We demonstrate
ifferential prevalence of hypertension, LVH, and abnormal
V remodeling across Hispanic subgroups, which illustrates
he heterogeneity of the Hispanic population. Efforts are
arranted to better recognize, understand, and address
ifferences among Hispanic ethnic groups to prevent CVD
vents in this large subset of the U.S. population.
cknowledgments
he authors thank the other investigators, the staff, and the
articipants of the MESA study for their valuable contri-
utions. A full list of participating MESA investigators and
nstitutions can be found at http://www.mesa-nhlbi.org.
eprint requests and correspondence: Dr. R. Graham Barr,
olumbia University, Department of Medicine, PH 9 East Room
05, 622 West 168th Street, New York, New York 10032. E-mail:
gb9@columbia.edu.
EFERENCES
1. Health Disparities Experienced By Hispanics Reported by: Office of
Minority Health, Office of the Director, CDC. Morb Mortal Wkly
Rep 2004;53:935–7.
2. Davidson JA, Kannel WB, Lopez-Candales A, et al. Avoiding the
looming Latino/Hispanic cardiovascular health crisis: a call to action.
Ethn Dis 2007;17:568–73.
3. Ramirez RR, dela Cruz GP. The Hispanic Population in the United
States: March 2002. Current Population Reports, P20-545. Washing-
ton, DC: U.S. Census Bureau, 2002.
4. Hanis CL, Hewett-Emmett D, Bertin TK, Schull WJ. Origins of U.S.
Hispanics. Implications for diabetes. Diabetes Care 1991;14:618–27.
5. Racial/ethnic disparities in prevalence, treatment, and control of
hypertension–United States, 1999–2002. MMWR Morb Mortal
Wkly Rep 2005;54:7–9.
6. Sacco RL, Boden-Albala B, Abel G, et al. Race-ethnic disparities in
the impact of stroke risk factors: the northern Manhattan stroke study.
Stroke 2001;32:1725–31.
7. Rodriguez CJ, Sciacca RR, Diez-Roux AV, et al. Relation between
socioeconomic status, race-ethnicity, and left ventricular mass: the
Northern Manhattan study. Hypertension 2004;43:775–9.
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
K
242 Rodriguez et al. JACC Vol. 55, No. 3, 2010
LV Mass and Remodeling Across Hispanic Subgroups January 19, 2010:234–428. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prog-
nostic implications of echocardiographically determined left ventricu-
lar mass in the Framingham Heart Study. N Engl J Med 1990;322:
1561–6.
9. Rodriguez CJ, Lin F, Sacco RL, et al. Prognostic implications of left
ventricular mass among Hispanics: the Northern Manhattan Study.
Hypertension 2006;48:87–92.
0. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular
geometric patterns in the Framingham Heart Study. J Am Coll
Cardiol 1995;25:879–84.
1. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic
significance of concentric remodeling of the left ventricle in hyperten-
sive patients with normal left ventricular mass. J Am Coll Cardiol
1995;25:871–8.
2. Moriuchi M, Saito S, Kasamaki Y, Komaki K, Kanmatsuse K,
Hayasaka K. [Three-dimensional analysis of left ventricular geometry
using magnetic resonance imaging: feasibility and comparison with
echocardiographic analysis]. J Cardiol 2003;42:249–60.
3. Verma A, Meris A, Skali H, et al. Prognostic implications of left
ventricular mass and geometry following myocardial infarction: the
VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocar-
diographic Study. J Am Coll Cardiol Img 2008;1:582–91.
4. Gonzalez Burchard E, Borrell LN, Choudhry S, et al. Latino popu-
lations: a unique opportunity for the study of race, genetics, and social
environment in epidemiological research. Am J Public Health 2005;
95:2161–8.
5. Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeco-
nomic, cultural, and behavioral factors affecting Hispanic health
outcomes. J Health Care Poor Underserved 2002;13:477–503.
6. Flegal KM, Ezzati TM, Harris MI, et al. Prevalence of diabetes in
Mexican Americans, Cubans, and Puerto Ricans from the Hispanic
Health and Nutrition Examination Survey, 1982–1984. Diabetes Care
1991;14:628–38.
7. Bild DE, Detrano R, Peterson D, et al. Ethnic differences in coronary
calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).
Circulation 2005;111:1313–20.
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension 2003;42:1206–52.
9. Natori S, Lai S, Finn JP, et al. Cardiovascular function in multi-ethnic
study of atherosclerosis: normal values by age, sex, and ethnicity. AJR
Am J Roentgenol 2006;186:S357–65.
0. Keller AM, Peshock RM, Malloy CR, et al. In vivo measurement of
myocardial mass using nuclear magnetic resonance imaging. J Am Coll
Cardiol 1986;8:113–7.
1. Dewey FE, Rosenthal D, Murphy DJ Jr., Froelicher VF, Ashley EA.
Does size matter? Clinical applications of scaling cardiac size and
function for body size. Circulation 2008;117:2279–87.
2. Bluemke DA, Kronmal RA, Lima JA, et al. The relationship of left
ventricular mass and geometry to incident cardiovascular events: the
MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll
Cardiol 2008;52:2148–55.
3. Rothman KJ. No adjustments are needed for multiple comparisons.
Epidemiology 1990;1:43–6.
4. Heckbert SR, Post W, Pearson GD, et al. Traditional cardiovascular
risk factors in relation to left ventricular mass, volume, and systolic
function by cardiac magnetic resonance imaging: the Multiethnic
Study of Atherosclerosis. J Am Coll Cardiol 2006;48:2285–92. y5. Allison MA, Budoff MJ, Wong ND, Blumenthal RS, Schreiner PJ,
Criqui MH. Prevalence of and risk factors for subclinical cardiovas-
cular disease in selected US Hispanic ethnic groups: the Multi-Ethnic
Study of Atherosclerosis. Am J Epidemiol 2008;167:962–9.
6. American Heart Association. Heart disease and stroke statistics—2009
update. Circulation 2009;119:e21–181.
7. Liao Y, Cooper RS, Cao G, Kaufman JS, Long AE, McGee DL.
Mortality from coronary heart disease and cardiovascular disease
among adult U.S. Hispanics: findings from the National Health
Interview Survey (1986 to 1994). J Am Coll Cardiol 1997;30:1200–5.
8. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda
HP. All-cause and cardiovascular mortality among Mexican-American
and non-Hispanic White older participants in the San Antonio Heart
Study: evidence against the “Hispanic paradox.” Am J Epidemiol
2003;158:1048–57.
9. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB.
Relation of arterial structure and function to left ventricular geometric
patterns in hypertensive adults. J Am Coll Cardiol 1996;28:751–6.
0. Cuspidi C, Macca G, Michev I, et al. Left ventricular concentric
remodelling and extracardiac target organ damage in essential hyper-
tension. J Hum Hypertens 2002;16:385–90.
1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH.
Relation of left ventricular mass and geometry to morbidity and
mortality in uncomplicated essential hypertension. Ann Intern Med
1991;114:345–52.
2. Devereux RB, Roman MJ, de Simone G, et al. Relations of left
ventricular mass to demographic and hemodynamic variables in
American Indians: the Strong Heart Study. Circulation 1997;96:
1416–23.
3. Fang ZY, Yuda S, Anderson V, Short L, Case C, Marwick TH.
Echocardiographic detection of early diabetic myocardial disease. J Am
Coll Cardiol 2003;41:611–7.
4. Julius S, Li Y, Brant D, Krause L, Buda AJ. Neurogenic pressor
episodes fail to cause hypertension, but do induce cardiac hypertrophy.
Hypertension 1989;13:422–9.
5. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence,
awareness, treatment, and control of hypertension among United
States adults 1999–2004. Hypertension 2007;49:69–75.
6. Moran A, Roux AV, Jackson SA, et al. Acculturation is associated
with hypertension in a multiethnic sample. Am J Hypertens 2007;20:
354–63.
7. Markides KS, Lee DJ, Ray LA. Acculturation and hypertension in
Mexican Americans. Ethn Dis 1993;3:70–4.
8. Bertoni B, Budowle B, Sans M, Barton SA, Chakraborty R. Admix-
ture in Hispanics: distribution of ancestral population contributions in
the Continental United States. Hum Biol 2003;75:1–11.
9. Bonilla C, Shriver MD, Parra EJ, Jones A, Fernandez JR. Ancestral
proportions and their association with skin pigmentation and bone
mineral density in Puerto Rican women from New York city. Hum
Genet 2004;115:57–68.
0. Laffer CL, Elijovich F. Essential hypertension of Caribbean Hispan-
ics: sodium, renin, and response to therapy. J Clin Hypertens (Green-
wich) 2002;4:266–73.
ey Words: hypertension y hypertrophy y remodeling y epidemiology
Hispanics y magnetic resonance imaging.
